RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • KCI등재

        Effect of autologous platelet-rich plasma for treatment of recurrent pregnancy loss: a randomized controlled trial

        Leila Nazari,Saghar Salehpour,Sedighe Hosseini,Teibeh Hashemi,Nasrin Borumandnia,Elham Azizi 대한산부인과학회 2022 Obstetrics & Gynecology Science Vol.65 No.3

        ObjectiveRecurrent pregnancy loss (RPL) is a fertility problem for which no exact mechanism of abortion or efficient treatmenthas been described. This study was conducted between 2018 and 2019 to investigate the effectiveness of autologousplatelet-rich plasma (PRP) in improving the live birth rate of women with RPL who required in vitro fertilization (IVF). MethodsA total of 63 patients with at least two previous pregnancy losses and no specific cause detected for the RPL wereincluded and randomly assigned into two groups (PRP and control). Intrauterine infusion of 0.5 mL of autologous PRPwas performed 48 hours before embryo transfer in the PRP group. Women in the control group received standardtreatment. ResultsForty patients completed the study. The baseline and cycle characteristics of the participants did not differ significantlybetween the PRP and control groups. The clinical pregnancy rate was higher in the PRP group (35% vs. 20%, P=0.288). The live birth rate was 15% in the PRP group, but no live births were recorded in the control group (P=0.231). ConclusionThis is the first study to show that intrauterine infusion of PRP in patients with RPL who undergo IVF may increase thechance of live birth. 영어

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼